This brand name is authorized in Canada
The drug TROMBOJECT contains one active pharmaceutical ingredient (API):
|
1
Sodium tetradecyl sulfate
UNII Q1SUG5KBD6 - SODIUM TETRADECYL SULFATE
|
|
Sodium tetradecyl sulfate is a sclerosing agent. Intravenous injection causes intima inflammation and thrombus formation. This usually occludes the injected vein. Subsequent formation of fibrous tissue results in partial or complete vein obliteration that may or may not be permanent. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C05BB04 | Sodium tetradecyl sulfate | C Cardiovascular system → C05 Vasoprotectives → C05B Antivaricose therapy → C05BB Sclerosing agents for local injection |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: CA | Health Products and Food Branch | Identifier(s): 00511226, 00511234 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
